Khazanchi Jewellers Delivers Strong Q3 EBITDA Growth; Margins Expand by 181 Bps in Q3 and 185 Bps in 9M FY26

Mumbai (Maharashtra) [India], February 17: Khazanchi Jewellers Limited (BSE: 543953), one of the leading Indian jewellery companies specializing in gold, diamonds, precious stones, and bullion items has announced its unaudited Financial Results for Q3 & 9M FY26.

Key Financial Highlights

9M FY26 Financial Highlights

Total Revenue of ₹ 1,542.02 Cr, YoY growth of 34.04%

EBITDA of ₹ 89.12 Cr, YoY growth of 96.91%

EBITDA Margin of 5.78%, YoY expansion of 185 Bps

PAT of ₹ 63.82 Cr, YoY growth of 96.92%

PAT Margin of 4.14%, YoY expansion of 132 Bps

EPS of ₹ 25.76, YoY growth of 96.64%

Q3 FY26 Financial Highlights

Total Revenue of ₹ 589.26 Cr, YoY growth of 49.60%

EBITDA of ₹ 35.34 Cr, YoY growth of 114.51%

EBITDA Margin of 6.00%, YoY expansion of 181 Bps

PAT of ₹ 25.13 Cr, YoY growth of 103.02%

PAT Margin of 4.26%, YoY expansion of 112 Bps

EPS of ₹ 10.12, YoY growth of 102.40%

Commenting on the financial performance Mr. Rajesh Mehta, Chairman & Joint Managing Director, Khazanchi Jewellers Limited said “We delivered a strong and well-rounded performance in Q3 and 9M FY26, driven by sustained business momentum, improved operational efficiencies, and healthy demand across key product categories. Our continued focus on design innovation, brand building, inventory discipline, and customer experience further strengthened our market position and profitability.

Growth remained broad-based across both our B2B and B2C segments. While our wholesale business expanded its partner network and market reach, our retail segment witnessed encouraging traction supported by festive demand and improved realizations. This balanced performance strengthens our diversified model and will further help us accelerate sustainable growth in the coming periods.”

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Related Posts

Maximus International Closes FY26 with 18% Revenue Growth and Record Q4 Performance

New Delhi [India], June 4: Maximus International Limited (BSE: 540401), a premier manufacturer and distributor of specialty lubricants and petroleum products, announced its Board-approved audited financial results for the quarter and financial year ended 31st March…

TransBnk Rebrands to TBX; Expands its Vision for the Future of Corporate Banking

New Delhi [India], June 4: TransBnk, India’s leading tech-first corporate banking and financial infrastructure platform, today unveiled its strategic rebranding to TBX, underscoring the company’s evolution from a transaction banking…

You Missed

Dr. Shankar Ghanshamdas Andani Creates Literary History with 106 Self-Authored Books Published in a Single Day, Earns Multiple World Record Recognitions

  • By
  • June 4, 2026
Dr. Shankar Ghanshamdas Andani Creates Literary History with 106 Self-Authored Books Published in a Single Day, Earns Multiple World Record Recognitions

Pune Cardiologist Dr. Ranjit Jagtap Notes Rise in Heart Cases

  • By
  • June 4, 2026
Pune Cardiologist Dr. Ranjit Jagtap Notes Rise in Heart Cases

Have We Been Chanting Mantras Without Truly Understanding Them? Mehul Vora’s Decoding Mantras Re-examines Modern Spiritual Understanding

  • By
  • June 4, 2026
Have We Been Chanting Mantras Without Truly Understanding Them? Mehul Vora’s Decoding Mantras Re-examines Modern Spiritual Understanding

CRICKETER OF THE CENTURY: A Prediction Before the World Took Notice

  • By
  • June 4, 2026
CRICKETER OF THE CENTURY: A Prediction Before the World Took Notice

20,000+ Doctors and continuing – How Medisage AI Spread Through India’s Medical Community

  • By
  • June 4, 2026
20,000+ Doctors and continuing – How Medisage AI Spread Through India’s Medical Community

FUME Reaches 15,000 Clients Across India and Abroad, Establishing India’s Leading Diagnostic-First Root-Cause Metabolic Decoding Platform

  • By
  • June 4, 2026
FUME Reaches 15,000 Clients Across India and Abroad, Establishing India’s Leading Diagnostic-First Root-Cause Metabolic Decoding Platform